Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi, Studi e Ricerche

No. 63-64 (2023)

HCV elimination plan 2.0: A project to improve the path of people who use drugs with HCV in Lombardy

DOI
https://doi.org/10.3280/mis63-64-2023oa17234
Submitted
febbraio 6, 2024
Published
2024-05-08

Abstract

The objective of the project "HCV elimination plan 2.0 - Implementation of treatment paths in the SerD Centers of Lombardy for patients with HCV" was to better manage the patient journey of drug users (PWUD) with HCV through the implementation of treatment paths within the SerD centers in Lombardy. The working team started in 2022 building up a diagnostic therapeutic assistance path (PDTA) shared between all 25 units of the region and continued this year with the verification of its implementation.

References

  1. Aghemo A., Lampertico P., Colombo M. (2012). Assessing long-term treatment efficacy in chronic hepatitis B and C: between evidence and common sense. J Hepatol., 57(6): 1326-35. Doi: 10.1016/j.jhep.2012.06.025.
  2. AISF Associazione Italiana per lo Studio del Fegato (2020). Documento di indirizzo dell’Associazione Italiana per lo Studio del Fegato per l’uso razionale dei farmaci anti-HCV disponibili in Italia. Aggiornamento del 14 dicembre.
  3. Andriulli A., Stroffolini T., Mariano A., Valvano M.R., Grattagliano I., Ippolito A.M., Grossi A., Brancaccio G., Coco C., Russello M., Smedile A., Petrini E., Martini S., Gaeta G.B., Rizzetto M. (2018). Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. Eur J Intern Med., 53: 79-84. Doi: 10.1016/j.ejim.2018.02.015.
  4. ECDC-EMCDDA Prevention and control of infectious diseases among people who inject drugs – 2023 update. Doi: 10.2900/854004.
  5. European Association for the Study of the Liver (2020). EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol., 73(5): 1170-1218. Doi: 10.1016/j.jhep.2020.08.018.
  6. Fiore V., De Matteis G., Ranieri R., Saderi L., Pontali E., Muredda A. et al. (2021). HCV testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C. Int J Drug Policy, 90, 103055. Doi: 10.1016/j.drugpo.2020.103055.
  7. Gardini I., Bartoli M., Conforti M., Mennini F.S., Marcellusi A. (2019). Estimation of the number of HCVpositive patients in Italy. PLoS One, Oct 31, 14(10), e0223668. Doi: 10.1371/journal.pone.0223668.
  8. Kondili L.A., Andreoni M., Alberti A., Lobello S., Babudieri S., Roscini A.S., Merolla R., Marrocco W., Craxì A. (2021). Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression. Epidemics, Mar, 34, 100442. Doi: 10.1016/j.epidem.2021.100442.
  9. Riglietta M., Chiesa A., Cocca G., Ranieri R., Zilio V., & Gruppo di Lavoro Coordinamento UO Dipendenze Regione Lombardia, (2023). PDTA per la diagnosi e il trattamento in Regione Lombardia dell’infezione da HCV nelle carceri e nei Ser.D. Mission - Open Access, (60). Doi: 10.3280/mis60-2022oa15188.
  10. The Polaris Observatory HCV Collaborators (2022). Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol, published online Feb 15. Doi: 10.1016/S2468-1253(21)00472-6.
  11. WHO (2018). Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. July.

Metrics

Metrics Loading ...